The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.
Jun 27, 2023
0
1
(HealthDay)—The prevalence of atopic dermatitis (AD) is higher among patients with vitiligo or alopecia areata (AA), according to research published online Dec. 3 in JAMA Dermatology.
Dec 5, 2014
0
0
(HealthDay)—For patients with alopecia areata (AA), phototherapy with ultraviolet A-1 (UVA-1) is a promising treatment modality, according to a research letter published in the October issue of the International Journal ...
Sep 28, 2015
0
47
(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.
Sep 22, 2016
0
4
(HealthDay)—Hairstyles are a defining feature for many people, but some 'dos can also damage hair follicles.
Feb 1, 2019
0
2
You look in the mirror and notice you're going bald. It's a reality that many men must face.
Jan 17, 2022
0
2
For patients with recalcitrant alopecia areata totalis or universalis, methotrexate combined with prednisone yields complete hair regrowth in about 31 percent of patients, according to a study published online March 8 in ...
Mar 15, 2023
0
5
Does how much hair a man has matter in how he is perceived? The answer is yes, according to a new article published online by JAMA Facial Plastic Surgery.
Aug 25, 2016
0
8
In a review of 19 studies, researchers at Johns Hopkins say they can confirm a "strong association" between certain scalp-pulling hairstyles—many common among African-Americans—and the development of traction alopecia, ...
Apr 27, 2016
0
24
The Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United States every ...
Jun 14, 2022
0
8
